Company / Cash per Share
Glaukos Corp. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.61
FY2025
5-year range
$1.61 / $3.45
FY2021-FY2025
Trend
-53.4%
vs FY2024
Sector context
#94 of 146
Health Care
What the data says
At $1.61, Glaukos Corp.'s cash per share ranks #94 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.20 in FY2016 to $3.45 in FY2024.
Based on SEC 10-K filings.
1.61 in FY2025 with a 5-year CAGR of +2.3%.
Declined from $2.50 to $1.61 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -9.1%
- 5-Year CAGR
- +2.3%
- 10-Year CAGR
- -
Sector benchmark
#94 of 146 in Health CareTop 64% of 146This company $1.61 Sector average $27.70
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 53.4% year-over-year.
- Ranks #94 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.61 | -53.4% |
| FY2024 | $3.45 | +38.0% |
| FY2023 | $2.50 | +16.7% |
| FY2022 | $2.14 | +0.4% |
| FY2021 | $2.13 | +48.8% |
| FY2020 | $1.44 | +73.8% |
| FY2019 | $0.83 | +16.7% |
| FY2018 | $0.71 | -2.0% |
| FY2017 | $0.72 | +257.8% |
| FY2016 | $0.20 | -92.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026